Index of the report
Report FOR THE INVESTIGATION OF CHINESE MEDICAL AND PHARMACEUTICAL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET (2008) 5
The research foundation of CRO 5
1.The definition of CRO industry 5
2.The emergence of CRO 5
3.The service range of CRO 7
CHAPTER ONE THE ANALYSIS OF GLOBAL CRO INDUSTRY MARKET 8
Section I  The analysis of the development of CRO industry 8
1.The sales scale of global pharmaceutical market (2007-2008) 8
2. Top ten of global enterprises which invest into the research and development of new drugs (2005) 9
3. Top fifteen of global enterprises which invest into the research and development (2006-2007) 10
Section II  The analysis of the scales of global CRO markets 16
1. The analysis of global R & D expenses on new drugs (2007-2010) 16
2. The scale of global CRO market (2007-2010) 16
3. The prospect of global R & D outsourcing of new drugs 17
Section III  The analysis of CRO market structure in 2007 19
1.The analysis of R & D outsourcing of new drugs 19
2.The business structure of new drugs R & D outsourcing 20
3.The characteristics of the business structure of new drugs R & D outsourcing service 22
Section IV  The analysis of CRO local market in 2007 24
1. The structure of global CRO market 24
2. The analysis of American CRO industy 25
3. The analysis of Indian CRO market 29
4. The analysis of CRO market in Taiwan 30
Section V  The structure of the competition between CRO enterprises in 2007 31
1. The analysis of global CRO enterprises 32
2. The scan of the world's top CRO companies 34
CHAPTER TWO THE ANALYSIS OF CHNESE CRO MARKET 35
Section I  The analysis of the development of Chnese CRO 36
1.The development of CRO in China 36
2.The prospects of CRO in China 37
Section II  The analysis of domestic CRO market 38
1. Chinese CRO market between 2004 and 2007 39
2.The analysis of the business structure of domestic enterprises 40
Section III  The competition structure of domestic CRO market 41
1.The types of the characteristics of domestic CRO enterprises 42
2.The types of the business of domestic CRO enterprises 43
3. The domestic CRO companies 43
4. Zhongguancun biomedical R & D outsourcing Union (CRO) 46
5.The biomedical R & D outsourcing center in Shanghai Pudong New Area 48
Section V  The latest trends of the industry between 2007 and 2008 49
1. NovaMed completes financing the second round of venture capital 49
2. Sundia completes financing the second round venture capital in January of 2008 50
3. NovaSecta joins Chinese pharmaceutical R & D outsourcing company Union for the first time 51
CHAPTER TREE THE ANALYSIS OF DOMESTIC KEY ENTERPRISES 51
Section I  Pharma Tech 51
1.The introduction of the enterprise 52
2.The SWOT analysis of competitiveness 52
3.The analysis of the financial operation in 2007 56
Section II  The analysis of other enterprises 62
1.Shanghai Chempartner Co. Ltd. 62
2.Sandia medical technology (Shanghai) 63
3.Beijing MDS 64
4.Beijing KendleWits Medicine 67
5. Beijing Excel Medical Technology Development Co. Ltd. 67
6. Beijing Venturepharm Technology Co., Ltd. 69
7. Guangzhou Bo Ji State new drugs clinical research center 76
8. PHARMARON (Beijing) new drugs Technology Co., Ltd. 80
Notice 80

Index of Charts
TABLE 1  TOP TEN OF GLOBAL ENTERPRISES WHICH INVEST INTO R & D OF NEW DRUGS (2005) 9
TABLE 2  THE TREND OF GLOBAL ENTERPRISES WHICH INVEST INTO R & D (2006-2007) 10
TABLE 3   THE MARKET GROWTH OF CRO OF GLOBAL PHARMACEUTICAL INDUSTRIES (UNIT: 100 MILLION U.S. DOLLARS) 18
TABLE 4  THE GLOBAL CRO MARKET SHARE (UNIT: 100 MILLION U.S. DOLLARS; %) 24
TABLE 5  THE SALES VOLUME OF GLOBALLY KEY CRO ENTERPRISES IN 2007 32
TABLE 6  MAIN GLOBAL CRO INSTITUTES AND THEIR BUSINESS DIRECTIONS 33
TABLE 7  THE LIST OF PART OF DOMESTIC CRO ENTERPRISES 43
TABLE 8  SPONSORS OF ZHONGGUANCUN BIOMEDICAL R & D OUTSOURCING UNION (ALL IN RANDOM ORDER) 47
TABLE 9  PART OF ENTERPRISES ENGAGING IN BIOMEDICAL R & D OUTSOURCING SERVICE IN SHANGHAI PUDONG NEW AREA 48
TABLE 10  THE SWOT ANALYSIS OF PHARMATECH 52
TABLE 11  THE PROJECTS COMPLETED BY VPS 72
TABLE 12  THE PROJECTS WHICH ARE BEING OPERATED BY VPS 72

FIGURE 1  THE TREND OF THE GLOBAL CRO MARKET (2007-2010) 17
FIGURE 2  THE SCALE MAP OF THE OUTSOURCING MARKET VALUE OF NEW DRUGS R & D IN 2007 20
FIGURE 3  THE SCALE MAP OF THE OUTSOURCING MARKET VALUE OF NEW DRUGS R & D 21
FIGURE 4  THE MARKET SHARE OF GLOBAL LEADING INTERNATIONAL CRO SECTORS （2001） 33
FIGURE 5  THE TREND OF CHINESE CRO MARKET BETWEEN 2004 AND 2007(UNIT: HUNDRED MILLION YUAN) 39
FIGURE 6  THE REVENUE CHANGE OF (UNIT: MILLION DOLLARS) 64
FIGURE 7  THE REGIONAL RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN 2007 65
FIGURE 8  THE RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN TERMS OF DIFFERENT CUSTOMES IN 2007 65
FIGURE 9  THE RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN TERMS OF DIFFERENT BUSINESS STRUCTURES IN 2007 66